Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous concentrated bone marrow transplantation for idiopathic osteonecrosis of the femoral head
jRCTc032200229Recruiting
- Start
- Jan 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous concentrated bone marrow cells in idiopathic osteonecrosis of the femoral head (ONFH). Primary endpoint: Ratio of collapsed femoral head. Started Jan 2023; status: recruiting.
02
Drugs
autologous concentrated bone marrow cells
03
Conditions
idiopathic osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on jRCTc032200229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTc032200229.